Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|June 1, 1994
Comparative bioavailability of 5-aminosalicylic acid from a controlled release preparation and an azo-bond preparationL A Christensen, J Fallingborg, B A Jacobsen, et al.EJVES Short Reports|September 1, 2017
Body Mass Index and Operating Times in Vascular ProceduresM Durup-Dickenson, C W Nicolajsen, J Budtz-Lilly, et al.Scandinavian Journal of Gastroenterology|September 1, 1992
Primary sclerosing cholangitis in patients with ulcerative colitisH H Rasmussen, J Fallingborg, P B Mortensen, et al.Alimentary Pharmacology & Therapeutics|February 1, 1990
Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times dailyF Bendtsen, N Ebbehøj, J Fallingborg, et al.Journal of Pediatric Gastroenterology and Nutrition|August 1, 1990
Measurement of gastrointestinal pH and regional transit times in normal childrenJ Fallingborg, L A Christensen, M Ingeman-Nielsen, et al.Digestive Diseases and Sciences|October 1, 1993
Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal childrenL A Christensen, J Fallingborg, B A Jacobsen, et al.Scandinavian Journal of Gastroenterology|January 1, 1986
Microscopic appearance of the esophageal mucosa in a consecutive series of patients submitted to upper endoscopy. Correlation with gastroesophageal reflux symptoms and macroscopic findingsP Funch-Jensen, K Kock, L A Christensen, et al.Scandinavian Journal of Gastroenterology|June 1, 1994
Effect of olsalazine and mesalazine on intraluminal pH of the duodenum and proximal jejunum in healthy humansJ Fallingborg, L A Christensen, B A Jacobsen, et al.Scandinavian Journal of Gastroenterology|April 1, 1991
Availability of mesalazine (5-aminosalicylic acid) from enemas and suppositories during steady-state conditionsB A Jacobsen, K Abildgaard, H H Rasmussen, et al.Alimentary Pharmacology & Therapeutics|October 1, 1990
Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in manL A Christensen, J Fallingborg, K Abildgaard, et al.Pageof 5